Myles McNulty, Discover and Read the Best of Twitter Threads by @MylesMcNulty

Myles McNulty

MylesMcNulty

Absolute terror reigns over many #AVCT shareholders this week- simply because @avacta hasn't announced orders for its LFT yet.Question: would #AVCT be lining up 30m per month capacity overseas, if

ST trade: multiple purchases this week in #AVCT, av. 169p. Separate from core LT hold.'Bad' news (i.e. slower build up in manufacturing capacity than envisaged by most; no commercial orders

Really didn't expect to see #MKA back below 9p. At 8.65p, its mkt cap is £11.5m.Its 2015 PFS projected annual EBITDA of ~$100m over two decades.As a result of its

Seen a few comments about #AVCT being the most expensive of the #COVID19 diagnostics stocks.Many investors seem only to look at the £460m mkt cap and lack of current sales.

#AVCT interims tomorrow.Comprehensive updates on all work streams of the Therapeutics and Diagnostics divisions will be provided.Naturally, the content will likely be dominated by the various #COVID19 products under development

Immense interims from #NCYT. Notable points:- Revenue increase YoY of 900%, to €72.4m- 91% of revenue (~€66m) generated in Q2- PAT margin of 56% (€40.2m). An extraordinary margin- Inventory of

More great news from #AVCT: it has developed a research use only ('RUO') ELISA test for #COVID19.There are also a number of very helpful snippets and implications in the RNS

#SAE @simecatlantis: a quick delve into developments at Uskmouth and the overall power plant conversion division.Specifically re: Uskmouth, the importance of a particular update in the 16/07/2020 RNS has been

I was not intending to comment on #AVCT again until more solid news-flow, but I've had numerous messages today about the current 14% drop in the SP.For me, it's simply

Added just shy of 2m shares to #N4P the past two days, the majority of it in the placing.Needless to say, not a great price - but we look forward.Co